Piramal Pharma Limited has informed the Exchange about exercise of call option to acquire the balance 26% equity stake in Yapan Bio Private Limited
EarningsCanvas
Loading your research…
Opening the latest published company and exchange records.
EarningsCanvas
Opening the latest published company and exchange records.
NSE · NSE SME · BSE
Results, orders and company updates, with a trail back to the filing. Check the feed status below for freshness.
Exchange intelligence
An exchange could not be refreshed. These are last known disclosures. Check the official exchange for newer announcements.
Piramal Pharma Limited has informed the Exchange about exercise of call option to acquire the balance 26% equity stake in Yapan Bio Private Limited
Intimation of Schedule of Institutional Investor Meetings under the SEBI LODR Regulations, 2015
Piramal Pharma Limited has informed the Exchange about Transcript
Piramal Pharma Limited has informed the Exchange about Link of Recording
Piramal Pharma Limited has informed the Exchange about Presentation
Piramal Pharma Limited has informed the Exchange about Investor Presentation
Piramal Pharma Limited has informed the Exchange regarding a press release dated October 27, 2026, titled "Piramal Pharma Limited Announces Results for Q2 and H1 FY2".
Piramal Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.